Sarilumab | m-entrepreneurship.com

Product Name :
Sarilumab

Search keywords :
Oncostatin M

drugId :
null

Target Vo:
Interleukin-6 receptor alpha subunit

Target Vo Short Name :
IL6RA

Moa_Name:
Interleukin-6 receptor alpha subunit antagonists

First Approval Country :
United States

First Approval Date Filter:
2017

Origin Company_Name :
Sanofi

Active Company_Name :
Clinica Universidad De Navarra

Active Indication_Name:
Arthritis, Juvenile

In Active Indication_Name:
Non-radiographic axial spondyloarthritis

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
VEGF Receptor 1 Antibody
Cy3-conjugated AffiniPure Goat Anti-Mouse IgG H&L
CYP11A1 Antibody: CYP11A1 Antibody is an unconjugated, approximately 53/57 kDa, rabbit-derived, anti-CYP11A1 polyclonal antibody. CYP11A1 Antibody can be used for: WB, ELISA, IHC-P, IHC-F, Flow-Cyt, ICC, IF expriments in human, mouse, rat, and predicted: dog, pig, cow, horse, rabbit, sheep background without labeling.

Author: Betaine hydrochloride

Related Posts